Synopsis
In the chaotic aftermath of World War II, as Berlin lay divided into four sectors under Allied control, the city's underbelly erupted into a frenzy of rampant drug use, shattering the strict anti-drug edicts that had defined the Nazi regime. In the American zone, Arthur J. Giuliani, an agent from the newly formed Federal Bureau of Narcotics, was dispatched on a covert mission to sift through the ruins of the Third Reich's pharmaceutical secrets, scavenging documents and compounds that might bolster U.S. enforcement strategies—or, more insidiously, serve emerging intelligence needs. What Giuliani uncovered was no mere bureaucratic curiosity: it was the hidden undercurrents of Nazi experimentation with psychedelics, particularly LSD, a substance first synthesized in 1938 by Swiss chemist Albert Hofmann at Sandoz Laboratories as a potential circulatory and respiratory stimulant. Far from the regime's publicized teetotaler image, high-ranking SS officers and scientists had quietly procured batches of this powerful hallucinogen, testing it on concentration camp prisoners and POWs in desperate bids to engineer a "truth serum" for interrogations, enhance soldier performance, and unravel the human mind for wartime advantage. These experiments, conducted in the shadows of places like Dachau and Auschwitz, revealed LSD's capacity not just for disorientation but for profound psychological disruption, planting seeds of weaponized mind control that would outlive the Reich.
As the Cold War dawned, Giuliani's haul crossed the Atlantic, igniting a feverish collaboration between American spymasters and the very Nazi researchers they had ostensibly defeated. Operation Paperclip funneled ex-SS scientists like Kurt Blome—infamous for his biological warfare programs—into U.S. employ, where they traded their knowledge of mescaline and LSD derivatives for immunity and new laboratories. By 1950, Harvard anesthesiologist Dr. Henry Beecher, fresh from wartime service, was enlisted by the government to dissect these captured files, bridging the gap between Nazi pseudoscience and legitimate pharmacology. What emerged was a transatlantic pipeline of forbidden research, fueling the CIA's descent into the abyss of Project MKUltra, the sprawling 1950s-1960s initiative that dosed unwitting civilians, soldiers, and even agency operatives with LSD in hallucinatory quests for programmable assassins and unbreakable espionage tools. Ohler vividly reconstructs these episodes through declassified memos and personal diaries, portraying figures like CIA director Allen Dulles as architects of a "brain warfare" empire, where acid trips were scripted in sterile basements from Langley to San Francisco, often with catastrophic results—overdoses, breakdowns, and suicides that the agency buried under layers of redacted denial.
Yet Tripped transcends mere chronicle of covert horrors, tracing how this militarized legacy curdled into cultural and political backlash. As whispers of MKUltra's excesses leaked into the 1960s counterculture, LSD escaped the lab to become the sacrament of hippies and rebels, from Timothy Leary's proselytizing at Millbrook to the acid-fueled anthems of the Summer of Love, inadvertently fulfilling the Nazis' dream of mass psychological upheaval but in a subversive, liberating key. Ohler argues that the same substance once touted for control now shattered taboos, influencing everything from Vietnam-era protests to John F. Kennedy's dovish olive branches, though always shadowed by the ghosts of its origins. The irony deepened when the CIA, fearing its own creation turning against it, pivoted to suppression: leaked scandals in the 1970s prompted a draconian crackdown, with the Federal Bureau of Narcotics—Giuliani's old outfit—lobbying to classify psychedelics as Schedule I poisons, effectively criminalizing therapeutic inquiry for generations. This zero-tolerance zeal, Ohler contends, was no organic moral panic but a direct inheritance from the Third Reich's punitive drug laws, repackaged to safeguard national security and pharmaceutical monopolies, stunting research into LSD's potential for treating alcoholism, schizophrenia, and trauma until the fragile renaissance of the 21st century.
Through meticulous archival dives across Swiss vaults, Berlin bunkers, and Washington archives, Ohler—building on his explosive Blitzed—unspools this narrative with propulsive wit and unflinching detail, humanizing the era's mad scientists and broken test subjects while indicting the enduring cost of secrecy. Tripped ultimately laments a forked path: one where psychedelics might have healed the postwar psyche, unburdened by weaponization, and another where their demonization entrenched America's War on Drugs, a spectral war whose battle lines were first sketched in the smoke-filled rooms of a defeated empire. In reclaiming this suppressed saga, Ohler not only demystifies the dawn of the psychedelic age but challenges us to reckon with its unfinished revolution, where the line between liberation and control remains as blurred as a bad trip.